REGENERON PHARMACEUTICALS, INC. ($REGN)
Filing Information
| Accession Number | 0001187443-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
13
Total Shares
100
Total Value
$78,549.55
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 2, 2026 | Sale | 7 | $777.46 | $5,442.22 | 17,796 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 2 | $778.30 | $1,556.60 | 17,794 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 5 | $779.69 | $3,898.45 | 17,789 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 3 | $780.69 | $2,342.07 | 17,786 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 2 | $781.21 | $1,562.42 | 17,784 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 2 | $782.62 | $1,565.24 | 17,782 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 10 | $783.62 | $7,836.20 | 17,772 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 9 | $784.48 | $7,060.32 | 17,763 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 11 | $785.48 | $8,640.28 | 17,752 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 7 | $786.61 | $5,506.27 | 17,745 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 2 | $787.34 | $1,574.68 | 17,743 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 20 | $788.96 | $15,779.20 | 17,723 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 20 | $789.28 | $15,785.60 | 17,703 | Direct | โ | View Details |